By: Bioenvelop Div Squire Pharmaceuticals  09-12-2011
Keywords: Film, patent

BioEnvelop™ differentiates itself with its Thinsol Technology. Thinsol™ is a water-based, enzymatically-digested carboxymethylcellulose (CMC-enz) film that is suitable for the rapid delivery of pharmaceutical and nutraceutical active ingredients. BioEnvelop™ has submitted a patent application for this novel oral ingestible film composition delivery system, Thinsol™.

Thinsol™ may offer significant advantages over current edible film technologies. BioEnvelop's™ research has determined that use of the Thinsol™ delivery technology allows for the development of products that others may not be able to formulate in a film strip format, such as products that are heat-sensitive and those that require high drug loads on each strip.

Key Benefits:

Keywords: Film, patent

Contact Bioenvelop Div Squire Pharmaceuticals

Email - none provided

Print this page